Ban on Import of Raw Materials from 10 Chinese Firms

by Kathy Jones on  June 15, 2010 at 9:51 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The Drug Controller General of India (DCGI) has decided to impose a ban on import of raw material from 10 Chinese drug companies citing non-compliance with manufacturing standards.
 Ban on Import of Raw Materials from 10 Chinese Firms
Ban on Import of Raw Materials from 10 Chinese Firms

The DCGI cancelled the registration of these firms last week, which means that they will nopt be able to export raw material to Indian companies.

"A limited number of Chinese companies supply some of the active pharmaceutical ingredients (APIs) so there can be shortage for that particular lot," an industry executive told the Economic Times.

Some of the ingredients, which were supplied by these firms include clotrimazole, mefenamic acid and sulphadoxine. It is believed that the Chinese firms failed to supply good manufacturing practices (GMP) certificates.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive